Avantax Advisory Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.09M Buy
6,762
+754
+13% +$122K 0.01% 1115
2025
Q1
$1.02M Sell
6,008
-2,679
-31% -$456K 0.01% 1081
2024
Q4
$1.44M Buy
8,687
+4,655
+115% +$774K 0.01% 878
2024
Q3
$693K Buy
4,032
+298
+8% +$51.2K ﹤0.01% 1212
2024
Q2
$575K Buy
3,734
+316
+9% +$48.7K ﹤0.01% 1281
2024
Q1
$526K Buy
3,418
+21
+0.6% +$3.23K ﹤0.01% 1010
2023
Q4
$537K Buy
3,397
+917
+37% +$145K 0.01% 953
2023
Q3
$363K Sell
2,480
-177
-7% -$25.9K ﹤0.01% 1087
2023
Q2
$407K Buy
2,657
+136
+5% +$20.8K ﹤0.01% 1029
2023
Q1
$391K Sell
2,521
-29
-1% -$4.5K ﹤0.01% 1016
2022
Q4
$393K Buy
2,550
+295
+13% +$45.5K 0.01% 975
2022
Q3
$298K Sell
2,255
-25
-1% -$3.3K ﹤0.01% 1016
2022
Q2
$309K Sell
2,280
-99
-4% -$13.4K ﹤0.01% 991
2022
Q1
$353K Sell
2,379
-2,857
-55% -$424K ﹤0.01% 929
2021
Q4
$848K Sell
5,236
-6,464
-55% -$1.05M 0.01% 570
2021
Q3
$1.93M Sell
11,700
-3,155
-21% -$521K 0.03% 340
2021
Q2
$2.56M Sell
14,855
-2,543
-15% -$438K 0.05% 284
2021
Q1
$2.79M Sell
17,398
-1,310
-7% -$210K 0.06% 238
2020
Q4
$3.14M Sell
18,708
-539
-3% -$90.6K 0.07% 186
2020
Q3
$3.04M Buy
19,247
+3,502
+22% +$553K 0.05% 278
2020
Q2
$2.65M Buy
15,745
+2,926
+23% +$492K 0.08% 181
2020
Q1
$1.69M Buy
12,819
+7,631
+147% +$1M 0.05% 216
2019
Q4
$764K Buy
5,188
+3,398
+190% +$500K 0.02% 389
2019
Q3
$224K Buy
+1,790
New +$224K 0.01% 511
2019
Q2
Sell
-1,350
Closed -$204K 529
2019
Q1
$204K Buy
+1,350
New +$204K 0.01% 458